Tekturna Combinations Targeted To Jumpstart Renin Inhibitor’s Sales
This article was originally published in The Pink Sheet Daily
Executive Summary
CEO Vasella maintains Tekturna has blockbuster potential; aliskiren combination with Diovan could be on the horizon.